drugset / Trial / NCT03333265
Primary Chemoprevention of Familial Adenomatous Polyposis With Berberine Hydrochloride
RandomizedParallel-groupTriple-blindPrevention
Summary
In recent years, Berberine hydrochloride has been reported to inhibit cancer cell proliferation and to be cytotoxic towards cancer cells. Patients with familial adenomatous polyposis have a nearly 100 percent risk of colorectal cancer. The aim of this study is to investigate the chemopreventive effects Berberine hydrochlorid on the regression of colorectal adenomas.
Timeline
- Start
- 2017-09-01
- Primary completion
- 2020-08-31
- Completion
- 2021-06-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Berberine | Traditional medicine (herbal / TCM) | 100 mg | Oral |
| Subject | Berberine | Traditional medicine (herbal / TCM) | 300 mg | Oral |